KO
Kotak Healthcare Fund Direct Growth
Latest NAV
+28.78% 1Y
Sign In to Add to Portfolio
Benchmark: NIFTY Healthcare TRI
Expense ratio
1.09%
AUM
₹768 Cr
Min SIP
₹100
Min lump sum
₹100
1Y
+28.78%
3Y (ann.)
+0.00%
5Y (ann.)
+0.00%
Launched
Dec 2023
Where the NAV sits & how risky it is
₹17.60
52-week range
at 88%
₹17.60
Low 29 Jan 2026₹13.04
High 23 Sep 2026₹18.24
Risk level
Very High
Low
Very high
NAV history
12 Dec 2023
Since inception
01 Oct 2026
Returns by period
1W
-2.68%
1M
-0.20%
3M
+6.11%
6M
+29.54%
1Y
+28.78%
3Y
+0.00%
5Y
+0.00%
3Y and 5Y returns are annualised.
Return calculator
You invest
—
Est. gain
—
Est. value
—
Invested Gain
Invested
Projected value
min SIP ₹100
Estimate only. It assumes the selected past return repeats every year; 3Y and 5Y figures are taken as annualised. Actual returns vary and are not guaranteed.
Where your money goes
AS OF 31 MAY 2026
Equity 98.84%
Cash & other 1.42%
Sector split
Country split
Top 5 hold 35.6%
Top 10 hold 55.3%
34 equity holdings
Equity holdings
(top 30)
| # | Holding | Sector | Country | Weight | YTD |
|---|---|---|---|---|---|
| 1 | Sun Pharmaceutical
INE044A01036 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
13.01%
|
+4.09% |
| 2 | J B Chemicals and Pharmaceuticals
INE572A01036 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
6.23%
|
+22.67% |
| 3 | Divis Laboratories
INE361B01024 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
5.95%
|
+5.64% |
| 4 | Max Healthcare Institute
INE027H01010 |
Healthcare Medical Care Facilities |
India |
5.43%
|
-4.02% |
| 5 | Cipla
INE059A01026 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
5.00%
|
-8.06% |
| 6 | Acutaas Chemicals
INE00FF01025 |
Basic Materials Specialty Chemicals |
India |
4.92%
|
+87.82% |
| 7 | Fortis Healthcare
INE061F01013 |
Healthcare Medical Care Facilities |
India |
4.31%
|
+11.96% |
| 8 | Park Medi World
INE119201023 |
Healthcare Medical Care Facilities |
India |
4.20%
|
+99.59% |
| 9 | Mankind Pharma
INE634S01028 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
3.18%
|
+8.86% |
| 10 | Krishna Institute of Medical Sciences
INE967H01025 |
Healthcare Medical Care Facilities |
India |
3.12%
|
+28.43% |
About this scheme
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. However, there is no assurance that the objective of the scheme will be achieved .
Fund manager(s): Abhishek Bisen, Dhananjay Tikariha
Exit load: 0.5% for redemption within 30 Days
Scheme snapshot
VR Rating
MS Rating
Plan
Growth
Type
DIRECT
Inception
11 Dec 2023
Lump-sum min
₹100
SIP
Purchase
Switch
STP
SWP
Similar schemes
RANKED BY 1Y RETURN
Nippon India Taiwan Equity Fund Direct Growth
1▲ 92.8 pts ahead of this fund
Franklin Asian Equity Fund Direct Growth
2▲ 4.6 pts ahead of this fund
Nippon India Japan Equity Fund - Direct Plan - Growth Plan - Bonus Option
3▲ 1.8 pts ahead of this fund
Nippon India Japan Equity Fund Direct Growth
4▲ 1.8 pts ahead of this fund
Bank of India Small Cap Fund Direct Growth
5▲ 0.5 pts ahead of this fund
TRUSTMF Small Cap Fund Direct Growth
6▲ 0.4 pts ahead of this fund